EMA recommends approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic

View source ↗

Summary

EMA recommends approval of a new treatment for platinum-resistant ovarian cancer, coordinated with a companion diagnostic to identify eligible patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer